| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |